Source: DGNews | Posted 8 years ago
FDA Approves Paxil CR (Paroxetine) for Treatment of Premenstrual Dysphoric Disorder
Tags:
PHILADELPHIA, PA -- September 2, 2003 -- GlaxoSmithKline (NYSE: GSK) today announced the U.S. Food and Drug Administration (FDA) approved Paxil CR



Comments